🟢 Chimeric Therapeutics is trading 11.11% up today — unconfirmed rebound amid clinical overhang

Chimeric Therapeutics is trading at A$0.01, up 11.11%, with the gain appearing to be an unconfirmed rebound in a highly volatile, low-priced biotech.

• No new company-specific announcement explaining the August 31, 2026 move was identified.
• The dominant overhang remains the August 19 decision to cease CHM-2101 enrollment after dose-limiting toxicities; development is shifting toward an in vivo CAR program.